Surgery – Means for introducing or removing material from body for... – With means for cutting – scarifying – or vibrating tissue
Reexamination Certificate
2008-03-11
2008-03-11
Mendez, Manuel (Department: 3763)
Surgery
Means for introducing or removing material from body for...
With means for cutting, scarifying, or vibrating tissue
Reexamination Certificate
active
07341569
ABSTRACT:
In one embodiment of the present invention, a method of treating a vascular occlusion located at a treatment site within a patient's vasculature comprises positioning an ultrasound catheter at the treatment site. The method further comprises delivering a microbubble therapeutic compound from the ultrasound catheter to the vascular occlusion during a first treatment phase. The method further comprises pausing the delivery of the microbubble compound and delivering ultrasonic energy from the ultrasound catheter in combination with other therapeutic compounds to the vascular occlusion during a second treatment phase while the delivery of microbubble therapeutic compound remains paused.
REFERENCES:
patent: 2961382 (1960-11-01), Singher et al.
patent: 4466442 (1984-08-01), Hilmann et al.
patent: 4657543 (1987-04-01), Langer et al.
patent: 4657756 (1987-04-01), Rasor et al.
patent: 4762915 (1988-08-01), Kung et al.
patent: 4772594 (1988-09-01), Hashimoto et al.
patent: 4774958 (1988-10-01), Feinstein
patent: 4797285 (1989-01-01), Barenholz et al.
patent: 4844882 (1989-07-01), Widder et al.
patent: 4900540 (1990-02-01), Ryan et al.
patent: 4920954 (1990-05-01), Alliger et al.
patent: 4921478 (1990-05-01), Solano et al.
patent: 4936281 (1990-06-01), Stasz
patent: 4948587 (1990-08-01), Kost et al.
patent: 4953565 (1990-09-01), Tachibana et al.
patent: 5040537 (1991-08-01), Katakura
patent: 5069664 (1991-12-01), Guess et al.
patent: 5088499 (1992-02-01), Unger
patent: 5129883 (1992-07-01), Black
patent: 5149319 (1992-09-01), Unger
patent: 5156050 (1992-10-01), Schmid et al.
patent: 5158071 (1992-10-01), Umemura et al.
patent: 5197946 (1993-03-01), Tachibana
patent: 5269291 (1993-12-01), Carter
patent: 5277913 (1994-01-01), Thompson et al.
patent: 5315998 (1994-05-01), Tachibana et al.
patent: 5318014 (1994-06-01), Carter
patent: 5342292 (1994-08-01), Nita et al.
patent: 5342608 (1994-08-01), Moriya et al.
patent: 5362309 (1994-11-01), Carter
patent: 5368036 (1994-11-01), Tanaka et al.
patent: 5380273 (1995-01-01), Dubrul et al.
patent: 5440914 (1995-08-01), Tachibana et al.
patent: 5474531 (1995-12-01), Carter
patent: 5542935 (1996-08-01), Unger et al.
patent: 5558092 (1996-09-01), Unger et al.
patent: 5580575 (1996-12-01), Unger et al.
patent: 5585112 (1996-12-01), Unger et al.
patent: 5628728 (1997-05-01), Tachibana et al.
patent: 5630837 (1997-05-01), Crowley
patent: 5648098 (1997-07-01), Porter
patent: 5695460 (1997-12-01), Siegel et al.
patent: 5707608 (1998-01-01), Liu
patent: 5713848 (1998-02-01), Dubrul et al.
patent: 5718921 (1998-02-01), Mathiowitz et al.
patent: 5733572 (1998-03-01), Unger et al.
patent: 5735811 (1998-04-01), Brisken
patent: 5776429 (1998-07-01), Unger et al.
patent: 5817048 (1998-10-01), Lawandy
patent: 5836896 (1998-11-01), Rosenschein
patent: 5916192 (1999-06-01), Nita et al.
patent: 5997497 (1999-12-01), Nita et al.
patent: 6001069 (1999-12-01), Tachibana et al.
patent: 6024718 (2000-02-01), Chen et al.
patent: 6068857 (2000-05-01), Weitschies et al.
patent: 6096000 (2000-08-01), Tachibana et al.
patent: 6096070 (2000-08-01), Ragheb et al.
patent: 6113558 (2000-09-01), Rosenschein et al.
patent: 6135976 (2000-10-01), Tachibana et al.
patent: 6176842 (2001-01-01), Tachibana et al.
patent: 6210356 (2001-04-01), Anderson et al.
patent: 6228046 (2001-05-01), Brisken
patent: 6287271 (2001-09-01), Dubrul et al.
patent: 6296619 (2001-10-01), Brisken et al.
patent: 6416740 (2002-07-01), Unger
patent: 6508816 (2003-01-01), Shadduck
patent: 6524251 (2003-02-01), Rabiner et al.
patent: 6548047 (2003-04-01), Unger
patent: 6582392 (2003-06-01), Bennett et al.
patent: 6723063 (2004-04-01), Zhang et al.
patent: 6896659 (2005-05-01), Conston et al.
patent: 2001/0003790 (2001-06-01), Ben-Haim et al.
patent: 2001/0053384 (2001-12-01), Greenleaf et al.
patent: 2002/0041898 (2002-04-01), Unger et al.
patent: 2002/0151792 (2002-10-01), Conston et al.
patent: 2004/0019318 (2004-01-01), Wilson et al.
patent: 2004/0024347 (2004-02-01), Wilson et al.
patent: 2004/0049148 (2004-03-01), Rodriquez et al.
patent: 2004/0068189 (2004-04-01), Wilson et al.
patent: 2006/0264809 (2006-11-01), Hansmann et al.
patent: 2007/0083120 (2007-04-01), Cain et al.
patent: 1 252 885 (2002-10-01), None
patent: 1252885 (2002-10-01), None
patent: 2 180275 (1990-07-01), None
patent: H02-108275 (1990-07-01), None
patent: WO 80/01365 (1980-07-01), None
patent: WO 89/05159 (1989-06-01), None
patent: WO 89/05160 (1989-06-01), None
patent: WO 95/15118 (1995-06-01), None
patent: WO 96/15815 (1996-05-01), None
patent: WO 99/39738 (1999-08-01), None
PCT Search Report, PCT Application PCT/US2006/13531; Apr. 12, 2006.
B.D. Butler, J. clin. Ultrasound 14(5): 408-12 (Jun. 1986) Production of Microbubbles for Use as Echo Contrast Agents.
Bao et al., Transfection of a Reporter plasmid into Cultured Cells By Sonoporation In Vitro. vol. 23, Nov. 6, 1997.
Bleeker et al., J. Ultrasound, Med. 9(8): 461-71 (Aug. 1990) On the Application of Ultrsonic Contrast Agents for Blood Flowmetry and Assessment of Cardiac Perfusion.
Feinstein et al., J. Am. Coll. Cardiol. 3(1): 14-20 (Jan. 1984) Two-dimensional Contrast Echocardiography I. In Vitrro Development and Quantitative Analysis of Echo Contrast Agents.
Greenleaf et al.: Artifical Cavitation Nuclei Significantly Enhance Accoustically Induced Cell Transfection. vol. 24, No. 4 pp. 587-595, 1998.
Holland and R.E. Apfel, J. Acoust. Soc. Am. 88(5): 2059-2069 (Nov. 1990) Thresholds for Transient Caviation Produced by Pulsed Ultrsound in a Controlled Nuclei Environment.
Jeffers et al.; Evaluation of the Effect of Cavitation Activity on Drug-Ultrsound Synergisms, 1993.
Jeffers et al; Dimethylformamide as an Enhancer of Cavitation-Induced Cell Lysis In Vitro, vol. 97, No. 1, Jan. 1995.
Keller et al., J. Ultrasound Med. 5(9): 493-8 (Sep. 1986) Automated Production and Analysis of Echo Contrast Agents.
Kim, T.F., Medical news & Perspectives, JAMA 261(11):1542 (Mar. 17, 1989) Microbubbles Show Promise for Enhancing Ultrasound Signal, Image, Other Applications.
Lang et al., Circulation 75(1): 229-234 (Jan. 1987) Contrast Ultrasonography of the Kidney: a New Method for Evaluation of Renal Perfusion in Vivo.
Leong et al., Biomaterials, vol. 7: 364-371 (Sep. 1986) Polyanhydrides for Controlled Release of Bioactive Agents.
Meltzer et al., J. Clin. Ultrasound 8(2): 121-7 (Apr. 1980) The Source of Ultrsound Contrsct Effect.
Miller et al.; Sonoporation of Cultured Cells in the Rotation Tube Exposure Sysytem, vol. 25, No. 1, 1999.
Porter et al., Thrombolytic Enhancement With Perfluorocarbom-Exposed Sonicated Dextrosse Albumin Microbubbles, Nov. 1996.
Prat et al.; In Vivo Effects of Cavitation Alone or in Combination Wity Chemotherapy in a Peritoneal Carinomatosis in the Rat. vol. 68, pp. 13-17.
Price et al.; Delivery of Colloidal Particles and Red Blood Cell to Tissue Through Microvessel Ruptures Created By Targeted Microbubble Destruction With Ultrasound, Sep. 29, 1998.
Tachibana K.; Tachibana s.; Albumin Microbubble Echo-Contrast Materials as an Enhancer For Ultrasound Accelerated Thrombolysis, Sep. 1, 1995.
Unger et al., Ultrasound Enhances Gene Expression of Liposomal Transfection. vol. 32, No. 12, Dec. 1997.
Unger et al.; Acoustically Active Liposheres Containing Paclitaxel, vol. 11, No. 12, 1992.
Vandenburg et al., Am. Heart J., 115(4), 733-9 (Apr. 1988) Myocardial Risk Area and Peak Gray Level Measurement by Contrast Echocardiography: Effecct of Microbubble Size and Concentration, Injection Rate, and Coronary Vasodilation.
Wheatly et al., Biomaterials 11(19): 713-7 (Nov. 1990) Contrast Agents for Diagnostic Ultrsound: Development and Evaluation of Polymer-Coated Microbubbles.
Wu et al., Binding as Lysing of Blood Clots Using MRX-408, May 1998.
Hansmann Douglas R.
Soltani Azita
Ekos Corporation
Knobbe Martens Olson & Bear LLP
Mendez Manuel
LandOfFree
Treatment of vascular occlusions using ultrasonic energy and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of vascular occlusions using ultrasonic energy and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of vascular occlusions using ultrasonic energy and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2789320